Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Cost-effectiveness analysis of interferon Beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Health beliefs and physical activity behavior in adults with multiple sclerosis.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Novel Agents for Relapsing Forms of Multiple Sclerosis.
Retraction notice: Language abilities of patients with primary progressive multiple sclerosis: A preliminary group and case investigation.
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Association Between Physical Fitness and Cognitive Function in Multiple Sclerosis: Does Disability Status Matter?
Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Effects of yoga interventions on fatigue: a meta-analysis.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
Increased Th17 response to myelin peptides in pediatric MS.
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.
[Compensatory mechanisms in multiple sclerosis(review)].
Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Concepts for regulation of axon integrity by enwrapping glia.
Atorvastatin: Multiple Sclerosis.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.
Pages
« first
‹ previous
…
301
302
303
304
305
306
307
308
309
…
next ›
last »